Initial report on intraves1cal administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladder
- 1 May 1997
- Vol. 49 (3) , 471-475
- https://doi.org/10.1016/s0090-4295(96)00621-8
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Effects of N-trifluoroacetyladriamycin-14-valerate (AD-32) on human bladder tumor cell linesCancer Chemotherapy and Pharmacology, 1987
- In vivo effects of adriamycin or N-trifluoroacetyladriamycin-14-valerate on a mouse lymphomaEuropean Journal of Cancer and Clinical Oncology, 1983